Upregulation of adipose 11-Β-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen

Obesity

Volumn 16, Issue 4, 2008, Pages 731-735

  Paulsen, Søren K ^a   Nielsen, Maria P ^a   Richelsen, Bjørn ^a   Bruun, Jens M ^a   Flyvbjerg, Allan ^a   Pedersen, Steen B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ESTROGEN; INTERLEUKIN 1BETA;

ADIPOSE TISSUE; ANIMAL; ARTICLE; BODY COMPOSITION; BODY WEIGHT; CYTOLOGY; DRUG EFFECT; ENERGY METABOLISM; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; LIPECTOMY; MALE; METABOLIC SYNDROME X; METABOLISM; OBESITY; OVARIECTOMY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; UPREGULATION; WISTAR RAT;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; BODY WEIGHT; ENERGY METABOLISM; ESTROGENS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERLEUKIN-1BETA; LIPECTOMY; MALE; METABOLIC SYNDROME X; OBESITY; OVARIECTOMY; RATS; RATS, WISTAR; UP-REGULATION;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 41549142831     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.2     Document Type: Article

References (38)

1. Seckl JR, Morton NM, Chapman KE, Walker BR. Glucocorticoids and 11ß-hydroxysteroid dehydrogenase in adipose tissue. Recent Prog Horm Res 2004;59:359-393.
2. Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH. Cortisol metabolism in human obesity: Impaired cortisone cortisol conversion in subjects with central adiposity. J Clin Endocrinol Metab 1999;84:1022-1027.
3. Wake DJ, Walker BR. 11 ß-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Mol Cell Endocrinol 2004;215:45-54.
4. Seidell JC, Perusse L, Despres JP, Bouchard C. Waist and hip circumferences have independent and opposite effects on cardiovascular disease risk factors: the Quebec Family Study. Am J Clin Nutr 2001;74:315-321.
5. Richelsen B, Pedersen SB. Associations between different anthropometric measurements of fatness and metabolic risk parameters in non-obese, healthy, middle-aged men. Int J Obes Relat Metab Disord 1995;19:169-174.
6. Yusuf S, Hawken S, Ounpuu S et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649.
7. Tremollieres FA, Pouilles JM, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999;142:415-423.
8. Seed M, Knopp RH. Estrogens, lipoproteins, and cardiovascular risk factors: an update following the randomized placebo-controlled trials of hormone-replacement therapy. Curr Opin Lipidol 2004;15:459-467.
9. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr 1992:55:950-954.
10. Tchernof A, Poehlman ET, Despres JR Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000;26:12-20.
11. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
12. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
13. Harrison-Bernard LM, Raij L. Postmenopausal hypertension. Curr Hypertens Rep 2000;2:202-207.
14. Kanaya AM, Herrington D, Vittinghoff E et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2003;138:1-9.
15. Paulsen SK, Pedersen SB, Fisker S, Richelsen B. 11 ß-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization. Obesity (Silver Spring) 2007; 15:1954-1960.
16. Paulsen SK, Pedersen SB, Jorgensen JO et al. Growth hormone (GH) substitution in GH-deficient patients inhibits 11 ß-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue. J Clin Endocrinol Metab 2006;91:1093-1098.
17. Low SC, Chapman KE, Edwards CR et al. Sexual dimorphism of hepatic 11 ß-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. J Endocrinol 1994;143:541-548.
18. Jamieson PM, Nyirenda MJ, Walker BR, Chapman KE, Seckl JR. Interactions between oestradiol and glucocorticoid regulatory effects on liver-specific glucocorticoid-inducible genes: possible evidence for a role of hepatic 11 ß-hydroxysteroid dehydrogenase type 1. J Endocrinol 1999;160:103-109.
19. Low SC, Assaad SN, Rajan V, Chapman KE, Edwards CR, Seckl JR. Regulation of 11 ß-hydroxysteroid dehydrogenase by sex steroids in vivo: further evidence for the existence of a second dehydrogenase in rat kidney. J Endocrinol 1993;139:27-35.
20. Masuzaki H, Yamamoto H, Kenyon CJ et al. Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 2003;112:83-90.
21. Masuzaki H, Paterson J, Shinyama H et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001:294:2166-2170.
22. Kershaw EE, Morton NM, Dhillon H, Ramage L, Seckl JR, Flier JS. Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity. Diabetes 2005;54:1023-1031.
23. Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 2001;288:191-197.
24. Dieudonne MN, Sammari A, Dos SE et al. Sex steroids and leptin regulate 11ß-hydroxysteroid dehydrogenase I and P450 aromatase expressions in human preadipocytes: Sex specificities. J Steroid Biochem Mol Biol 2006;99:189-196.
25. Cohen PG. Estradiol induced inhibition of 11ß-hydroxysteroid dehydrogenase 1: an explanation for the postmenopausal hormone replacement therapy effects. Med Hypotheses 2005;64:989-991.
26. Gomez-Sanchez EP, Ganjam V, Chen YJ et al. Regulation of 11ß-hydroxysteroid dehydrogenase enzymes in the rat kidney by estradiol. Am J Physiol Endocrinol Metab 2003;285:E272-E279.
27. Lindsay RS, Wake DJ, Nair S et al. Subcutaneous adipose 11ß-hydroxysteroid dehydrogenase type 1 activity and messenger ribonucleic acid levels are associated with adiposity and insulinemia in Pima Indians and Caucasians. J Clin Endocrinol Metab 2003:88:2738-2744.
28. Desbriere R, Vuaroqueaux V, Achard V et al. 11ß- hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 2006;14:794-798.
29. Rask E, Walker BR, Soderberg S et al. Tissue-specific changes in peripheral Cortisol metabolism in obese women: increased adipose 11ß-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002;87:3330-3336.
30. Rask E, Olsson T, Soderberg S et al. Tissue-specific dysregulation of Cortisol metabolism In human obesity. J Clin Endocrinol Metab 2001;86:1418-1421.
31. Wake DJ, Rask E, Livingstone DE, Soderberg S, Olsson T, Walker BR. Local and systemic impact of transcriptional up-regulation of 11ß-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity. J Clin Endocrinol Metab 2003;88:3983-3988.
32. Engeli S, Bohnke J, Feldpausch M et al. Regulation of 11ß-HSD genes in human adipose tissue: influence of central obesity and weight loss. Obes Res 2004;12:9-17.
33. Goedecke JH, Wake DJ, Levitt NS et al. Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women. Clin Endocrinol (Oxf). 2006;65:81-87.
34. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Expression of 11ß-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 2002;87:5630-5635.
35. Michailidou Z, Jensen MD, Dumesic DA et al. Omental 11ß-hydroxysteroid dehydrogenase 1 correlates with fat cell size independently of obesity. Obesity (Silver Spring) 2007;15:1155-1163.
36. Wade GN. Gonadal hormones and behavioral regulation of body weight. Physiol Behav 1972;8:523-534.
37. Laudenslager ML, Wilkinson CW, Carlisle HJ, Hammel HT. Energy balance in ovariectomized rats with and without estrogen replacement. Am J Physiol 1980;238:R400-R405.
38. Stern JJ, Murphy M. The effects of thyroxine and estradiol benzoate on wheel running activity in female rats. Physiol Behav 1972;9:79-82.